About NanoString Technologies (NASDAQ:NSTG)
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic & Testing Substances
- Sub-Industry: N/A
- Symbol: NASDAQ:NSTG
- CUSIP: N/A
- Web: www.nanostring.com
- Market Cap: $246.5 million
- Outstanding Shares: 25,204,000
- 50 Day Moving Avg: $14.85
- 200 Day Moving Avg: $16.19
- 52 Week Range: $9.56 - $23.45
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.81
- P/E Growth: 0.00
- Annual Revenue: $101.82 million
- Price / Sales: 2.42
- Book Value: $2.07 per share
- Price / Book: 4.72
- EBITDA: ($35,930,000.00)
- Net Margins: -44.28%
- Return on Equity: -329.59%
- Return on Assets: -36.94%
- Debt-to-Equity Ratio: 0.93%
- Current Ratio: 4.22%
- Quick Ratio: 3.74%
- Average Volume: 224,800 shs.
- Beta: 1.07
- Short Ratio: 8.01
Frequently Asked Questions for NanoString Technologies (NASDAQ:NSTG)
What is NanoString Technologies' stock symbol?
NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."
How were NanoString Technologies' earnings last quarter?
NanoString Technologies, Inc. (NASDAQ:NSTG) issued its quarterly earnings data on Tuesday, August, 8th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.37) by $0.17. The company earned $34.59 million during the quarter, compared to the consensus estimate of $29.87 million. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. View NanoString Technologies' Earnings History.
When will NanoString Technologies make its next earnings announcement?
What guidance has NanoString Technologies issued on next quarter's earnings?
NanoString Technologies updated its FY17 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of ($2.20)-($2.03) for the period, compared to the Thomson Reuters consensus estimate of ($2.33). The company issued revenue guidance of $114-$118 million, compared to the consensus revenue estimate of $108.47 million.
Where is NanoString Technologies' stock going? Where will NanoString Technologies' stock price be in 2017?
4 equities research analysts have issued 1-year price targets for NanoString Technologies' stock. Their forecasts range from $19.00 to $20.00. On average, they anticipate NanoString Technologies' share price to reach $19.67 in the next twelve months. View Analyst Ratings for NanoString Technologies.
Who are some of NanoString Technologies' key competitors?
Some companies that are related to NanoString Technologies include ImmunoGen (IMGN), Invacare Corporation (IVC), Clementia Pharmaceuticals (CMTA), Lion Biotechnologies (IOVA), Jounce Therapeutics (JNCE), Surgery Partners (SGRY), uniQure N.V. (QURE), Sucampo Pharmaceuticals (SCMP), Rigel Pharmaceuticals (RIGL), Entellus Medical (ENTL), Progenics Pharmaceuticals (PGNX), Tabula Rasa Healthcare (TRHC), Selecta Biosciences (SELB), Syros Pharmaceuticals (SYRS), Atara Biotherapeutics (ATRA), Pharming Group (PHGUF), GenMark Diagnostics (GNMK) and Agenus (AGEN).
Who are NanoString Technologies' key executives?
NanoString Technologies' management team includes the folowing people:
- William D. Young, Independent Chairman of the Board
- R. Bradley Gray, President, Chief Executive Officer, Director
- James A. Johnson, Chief Financial Officer
- J. Chad Brown, Senior Vice President - Sales and Marketing
- Mary Tedd Allen, Senior Vice President - Operations
- Joseph M. Beechem Ph.D., Senior Vice President - Research and Development
- David W. Ghesquiere, Senior Vice President - Corporate & Business Development
- Elisha W. Finney, Director
- Nicholas G. Galakatos Ph.D., Director
- Robert M. Hershberg M.D. Ph.D., Director
Who owns NanoString Technologies stock?
NanoString Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include Nationwide Fund Advisors (0.19%). Company insiders that own NanoString Technologies stock include Barney Saunders, Charles P Waite Jr, David W Ghesquiere, James A Johnson, R Bradley Gray and Wayne Burns. View Institutional Ownership Trends for NanoString Technologies.
Who bought NanoString Technologies stock? Who is buying NanoString Technologies stock?
How do I buy NanoString Technologies stock?
Shares of NanoString Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is NanoString Technologies' stock price today?
MarketBeat Community Rating for NanoString Technologies (NASDAQ NSTG)MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of NanoString Technologies stock can currently be purchased for approximately $9.78.
Consensus Ratings for NanoString Technologies (NASDAQ:NSTG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||3 Hold Ratings, 1 Buy Rating|
|Consensus Rating:||Hold (Score: 2.25)|
|Consensus Price Target: ||$19.67 (101.09% upside)|Consensus Price Target History for NanoString Technologies (NASDAQ:NSTG)
Analysts' Ratings History for NanoString Technologies (NASDAQ:NSTG)
(Data available from 10/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/12/2017||Robert W. Baird||Lower Price Target||Outperform||$23.00 -> $19.00||N/A|
|10/12/2017||Janney Montgomery Scott||Downgrade||Buy -> Neutral||N/A|
|10/12/2017||Cowen and Company||Downgrade||Outperform -> Market Perform||N/A|
|4/20/2017||Morgan Stanley||Downgrade||Overweight -> Equal Weight||$23.00 -> $20.00||High|
|8/5/2016||BTIG Research||Reiterated Rating||Buy||$20.00||N/A|
Earnings History for NanoString Technologies (NASDAQ:NSTG)Earnings History by Quarter for NanoString Technologies (NASDAQ NSTG)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/8/2017||Q2 2017||($0.37)||($0.20)||$29.87 million||$34.59 million||View||Listen|
|5/4/2017||Q1 2017||($0.87)||($0.87)||$17.53 million||$18.10 million||View||Listen|
|3/1/2017||Q4 2016||($0.52)||($0.55)||$24.90 million||$25.23 million||View||Listen|
|11/2/2016||Q316||($0.52)||($0.51)||$23.46 million||$23.90 million||View||N/A|
|8/3/2016||Q2||($0.66)||($0.55)||$19.62 million||$22.60 million||View||N/A|
|5/5/2016||Q1||($0.69)||($0.74)||$14.92 million||$14.70 million||View||N/A|
|2/29/2016||Q4||($0.54)||($0.44)||$21.12 million||$22.30 million||View||N/A|
|11/2/2015||Q315||($0.50)||($0.49)||$15.44 million||$15.70 million||View||Listen|
|8/4/2015||Q215||($0.57)||($0.66)||$12.80 million||$13.10 million||View||N/A|
|5/6/2015||Q115||($0.58)||($0.81)||$12.10 million||$11.59 million||View||N/A|
|11/4/2014||Q314||($0.56)||($0.54)||$11.80 million||$12.30 million||View||N/A|
|8/5/2014||Q214||($0.71)||($0.58)||$10.20 million||$10.90 million||View||N/A|
|5/7/2014||Q114||($0.70)||($0.56)||$8.37 million||$8.70 million||View||N/A|
|2/26/2014||Q4||($0.89)||($0.60)||$9.61 million||$10.10 million||View||N/A|
Earnings Estimates for NanoString Technologies (NASDAQ:NSTG)
Current Year EPS Consensus Estimate: $-2.24 EPS
Next Year EPS Consensus Estimate: $-2.57 EPS
Dividend History for NanoString Technologies (NASDAQ:NSTG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for NanoString Technologies (NASDAQ:NSTG)
Insider Ownership Percentage: 24.40%Insider Trades by Quarter for NanoString Technologies (NASDAQ:NSTG)
Institutional Ownership Percentage: 92.98%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/3/2017||R Bradley Gray||Insider||Sell||1,100||$20.58||$22,638.00|| |
|12/6/2016||Wayne Burns||SVP||Sell||21,666||$22.04||$477,518.64|| |
|11/21/2016||Charles P Waite Jr||Director||Sell||588,024||$21.25||$12,495,510.00|| |
|11/11/2016||Barney Saunders||SVP||Sell||11,983||$22.48||$269,377.84|| |
|11/11/2016||James A Johnson||CFO||Sell||10,000||$22.57||$225,700.00|| |
|11/11/2016||R Bradley Gray||Insider||Sell||37,325||$22.49||$839,439.25|| |
|10/26/2016||Charles P Waite Jr||Director||Sell||42,489||$20.56||$873,573.84|| |
|9/8/2016||Charles P Waite Jr||Director||Sell||29,105||$16.51||$480,523.55|| |
|9/7/2016||Wayne Burns||SVP||Sell||3,961||$16.50||$65,356.50|| |
|8/30/2016||Charles P Waite Jr||Director||Sell||111,060||$16.57||$1,840,264.20|| |
|8/25/2016||Charles P Waite Jr||Director||Sell||40,363||$16.59||$669,622.17|| |
|8/22/2016||Charles P Waite Jr||Director||Sell||72,145||$16.61||$1,198,328.45|| |
|8/16/2016||Charles P Waite Jr||Director||Sell||257,698||$16.55||$4,264,901.90|| |
|3/2/2016||David W Ghesquiere||SVP||Sell||1,321||$14.86||$19,630.06|| |
|8/13/2015||Wayne Burns||SVP||Sell||30,000||$14.93||$447,900.00|| |
|12/2/2014||Barney Saunders||SVP||Sell||30,000||$14.93||$447,900.00|| |
|11/14/2014||Charles P Waite Jr||Director||Sell||14,632||$12.25||$179,242.00|| |
|9/8/2014||Charles P Waite Jr||Director||Sell||45,000||$11.21||$504,450.00|| |
|9/5/2014||Charles P Waite Jr||Director||Sell||86,942||$11.17||$971,142.14|| |
|9/3/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||35,000||$11.15||$390,250.00|| |
|8/19/2014||Charles P Waite Jr||Director||Sell||1,700||$12.01||$20,417.00|| |
|8/19/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||20,257||$12.05||$244,096.85|| |
|8/18/2014||Charles P Waite Jr||Director||Sell||18,557||$12.05||$223,611.85|| |
|8/18/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||11,925||$12.05||$143,696.25|| |
|8/15/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||28,801||$12.36||$355,980.36|| |
|6/13/2014||Charles P Waite Jr||Director||Sell||166,755||$15.08||$2,514,665.40|| |
|6/13/2014||Wayne Burns||SVP||Sell||4,900||$15.01||$73,549.00|| |
|6/12/2014||Barney Saunders||SVP||Sell||28,000||$15.04||$421,120.00|| |
|6/10/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||160,000||$15.48||$2,476,800.00|| |
|6/9/2014||Wayne Burns||SVP||Sell||20,100||$15.76||$316,776.00|| |
|7/1/2013||Lifesciences Ii L.P. Clarus||Major Shareholder||Buy||750,000||$10.00||$7,500,000.00|| |
Headline Trends for NanoString Technologies (NASDAQ:NSTG)
Latest Headlines for NanoString Technologies (NASDAQ:NSTG)
Loading headlines, please wait.
NanoString Technologies (NSTG) Chart for Monday, October, 23, 2017